1. Generics Bulletin
  2. >>Business
  3. >>Deals

Hikma To Pay Up $150m In US Opioid Settlement Framework

Company Faced Claims Of Failing To Report Suspicious Opioid Orders From 2006 To 2021

 
• By Urtė Fultinavičiūtė

Despite denying any wrongdoing, Hikma joins a group of companies that have agreed to pay big settlements for their alleged respective roles in the ongoing opioid epidemic in the US.

US flag with crushed tablets from bottle
The agreement will resolve the “vast majority” of Hikma’s opioid-related lawsuits • Source: Shutterstock

As the US continues to battle the opioid crisis, Hikma Pharmaceuticals has announced a $150m multi-state settlement to resolve opioid-related cases that were brought up by the US government against the UK-based firm.

If all conditions are satisfied, Hikma will pay up to $115m in cash and $35m in donations of Hikma’s naloxone

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business